Sep 15, 2020 / 02:15PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Well, good morning, everyone, and welcome to Day 2 of the Morgan Stanley Healthcare Conference 2020, and thanks for joining us here as we progress through our medical device presentations here in the morning.
It's my pleasure to have this year our first large-cap presentation of day 2, which is Stryker, and I've got multiple members of the management team with me, including Kevin Lobo, CEO; Glenn Boehnlein, CFO; and Preston Wells, VP of IR. Kevin is going to do a couple of quick slides here with his traditional preamble, those should be loaded in your screen. You should have those slides. You can see both the disclaimer and the slides on your screen. He's going to run through those, and then we're going to jump into Q&A.
With that Kevin, the floor is yours.
Kevin A. Lobo - Stryker Corporation - Chairman & CEO
Okay. Great. Thank you, David, and I am going to go quite briskly through these slides and then obviously have Q&A with David.
Let's start with Slide 3, which
Stryker Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers